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Introduction
Emergence of specialized organizations creates needs for 
the specific information for decision-making. Developing 
and maintaining specialized registers or databases is 
a valuable tool for achieving organizational goals by 
providing information to support such decision-making.1,2 
Specialized bibliographic registers save time by allowing 
specific and sensitive searches for records of documents of 
high relevance to the research question.3
The Cochrane Collaboration (1993 – present) is an 
international non-for-profit network of, amongst others, 
healthcare researchers, practitioners, and patients. This 
Collaboration works to summarize and synthesize 
available evidence to support informed decision-making 
in the healthcare sectors. The Collaboration’s main 
activity is producing high-quality systematic reviews of 
randomized controlled trials (RCTs).4 However, over the 
last two decades after its foundation, there are still only 
6230 reviews published on the Cochrane Library (June 
2017), and most are in need of update. Despite enormous 
efforts of thousands of researchers, there remain hundreds 
of thousands of clinically valuable randomized trials not 
summarized within reviews. Best evidence to support 
the health care decision-making is being wasted. It is 
not an impossible task to provide good coverage of all 
clinically useful and best evidence of the effects of health 
care in any one sub-specialty but it is a large and difficult 
task. Since a systematic review requires a long process 
including literature searching, de-duplication of search 
results, screening the search results, obtaining the full 
text of the reports, putting the publications from the same 
study together (studification), data extraction and meta-
analysis, it has become clear that study-based registers 
of randomized trials are integral to this task shortening 
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Introduction: Despite years of 
use of study-based registers for 
storing reports of randomized 
controlled trials (RCTs), the 
methodology used in developing 
such registers/databases has 
not been documented. Such 
registers are integral to the 
process of scientific reviewing. 
We document and discuss 
methodological aspects of the development and use of study-based registers. Although the 
content is focused on the study-based register of randomized/controlled clinical trials, this work 
applies to developers of databases of all sorts of studies related to the human, animals, cells, 
genes, and molecules.
Methods: We describe necessity, rationale, and steps for the development, utilization and 
maintenance of study-based registers as well as the challenges and gains for the organizations 
supporting systematic reviews of the published and unpublished literature.
Conclusion: The ultimate goal of having a study-based register is to facilitate efficient production 
of systematic reviews providing rapid, yet accurate, evidence for the decision-makers. We 
argue that moving towards study-based registers is an inevitable welcome direction and that 
infrastructures are ready for such movement.
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‘publication’ or ‘report’). However, a study may have several 
reports or publications and hence, several records in the 
register.13 For instance, the researchers may conduct one 
study but report it in several references such as conference 
abstracts, a dissertation, a poster, journal papers, an online 
trial registry record in "ClinicalTrials.Gov" and so on. 
Although the references are different in the format they 
all present some or all data from a single study and each 
is listed separately within the reference-based register. A 
reference-based register is the least resource-intensive and 
simplest register to assemble.13
A reference record in a reference-based register may 
consist of bibliographic information, abstract and 
indexing fields. This record may also contain a link to 
the full report of the reference or be the full report in 
itself (i.e. conference abstract).14,15 In such a register, the 
reference record may sometimes contain another link to 
other references of the same study,16 or a study name or 
unique identifier, such as online trial registry number.17 
Such reference records are the backbone of all the major 
bibliographic biomedical databases such as MEDLINE 
and communication between such databases and reference 
management packages is usually easy. This type of register 
may represent the totality of publishing activity, but, 
because of the ‘one-to-many’ issue of so-called ‘salami’ 
publication of one study, the register is not an accurate 
representation of the total research activity. 
2. Study-based registers
Conducting one study, the researchers usually published 
their data in more than one paper.18 It means that one 
study might have several reports. To represent the whole 
data, we should find, use and cite the whole study rather 
than one paper or one reference of the study. For those 
working in systematic reviewing – summarizing research 
activity rather than publishing activity – there is the 
necessity to work at the study level instead of the reference 
level. Every time a systematic review is conducted a study-
based register of some sort is created. Recognizing the 
wastage involved in disassembling these at the end of each 
review, some Cochrane groups now maintain study-based 
registers in which all references of one study are linked to a 
single meta-record called the ‘study record’ (also referred 
to as the ‘trial record’). 
The idea of linking related records to one meta-record 
is not a new concept in information science19 but it is 
the cornerstone of modern relational databases. At the 
most basic level, a study-based register consists of study 
records each of which links to all available references of 
each study.20 Further value may be added to the study 
record by having it contain structured study-specific 
meta-data such as data about who were the participants, 
what are healthcare Problems, what are Interventions and 
Comparator, and what Outcomes have been measured- 
so-called PICO framework.21,22 These metadata make it 
possible to run a very specific search for the particular 
the process for the reviewers to start a review with data 
extraction or meta-analysis.5,6 
From the very start the Cochrane Collaboration created 
a specialized register of relevant literature – now called 
the Cochrane Central Register of Controlled Trials 
(CENTRAL) – and has disseminated this in Cochrane 
Library.7-9 CENTRAL is now the largest bibliographic 
reference-based database of reports of randomized 
trials.10,11 It is an amalgamation of the individual Cochrane 
groups’ registers which, in turn, are developed from 
biomedical bibliographic databases such as EMBASE, 
MEDLINE and other sources such as conference 
proceedings.12 In such databases, the publications and 
the reports from the same study are not linked together 
and putting the salami of the study back together required 
massive efforts.
Slow production of update systematic reviews because 
of long process (6230 reviews in 20 years) and salami 
publication of trials were two main problems leading in 
the development of study-based registers. In recognition 
of the value of study-based registers for more efficient 
review production the methodology for development, 
utilization and maintenance of such register have been 
documented in this methodology paper.
Objectives
• To search the literature for relevant papers on study-
based registers. 
• To report the rationale methods of development and 
challenges of study-based registers for which relevant 
documentation seems remarkably sparse.
• To share more than two decades of practical 
experience in the creation and maintenance of study-
based registers of biomedical literature. 
Search methods
We ran a search to find relevant literature and to ensure the 
novelty of the current paper. Since the terminology in this 
topic is standard, we used the following search strategy on 
MEDLINE (1946 to Search Date) and EMBASE (1974 to 
2017 Week 34) via Ovid SP and updated this search on 
August 29, 2017:
Search Strategy: ("Study-Based" adj (Register* or 
Database*)).ti,ab.
We also searched all conference abstracts presented in 
Cochrane meetings. We did not identify any full published 
paper on the study-based registers but did identify many 
conference abstracts. We then contacted Cochrane 
Information Specialists and followed web searching to 
find all possibly relevant documents for this overview.
Specialized registers
1. Reference-based registers
Within a reference-based register (database) each record 
usually behaves as a separate independent entity. There is 
one record for each ‘reference’ (also referred as ‘citation’, 
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intervention relevant to a certain healthcare condition and 
retrieve all the related trials – and no more – at the click 
of a button. All the data and their associated meta-data 
are stored in data tables (Figure 1). One meta-record may 
also contain information about all relevant references. 
Even though a reference may have contained similar 
PICO meta-data there is no implicit guarantee that data in 
the one reference record accurately represents all activity 
within the study. A single reference often reports a subset 
of activity within the study.
The study record can also contain accurate controlled 
vocabulary26 describing the comparisons within the study 
(e.g. drug X versus drug Y for condition Z) with the 
potential for direct linking to the end review(s).27 Finally, 
the study record may also contain all tabulated data 
extracted from the full-text reports or the full primary 
dataset (Table 1).28
Rationale
The ‘unit of currency’ of systematic reviews of 
healthcare is the study – not a single reference or a single 
published paper. The undertaking of a systematic review 
necessitates the creation of some sort of study-based list 
or register whether it be by the reviewers or Information 
Specialist. If pre-prepared by the Information Specialist 
the final product can be more accurate, save the time of 
other researchers, and has the potential to be re-used to 
avoid duplication of effort in the future. Certainly, if the 
single reference is considered the main unit for systematic 
reviews, erroneous double or even triple counting of data 
from various references of a single study is a real danger 
(Box 1). The use of study-based registers decreases this 
danger – although it does not make it impossible.29
1. Reference-based register or study-based register?
Some research groups prefer to keep their trials register at 
a reference level. However, many in systematic reviewing 
research have made (what we feel to be) the inevitable 
move to becoming study-based. In reality, one has to 
underlie the other. The study-based register should sit 
over a clean repository of references.33-35
Moving to a study-based register depends on the 
research teams’ ethos and policies, planning and available 
resources. Holding a reference-based register will save 
search and de-duplication time. However, a study-based 
register allows Information Specialists not only to save 
that searching and de-duplicating time but also can 
benefit authors of reviews by providing study records with 
multiple references already organized at study level. Study-
based registers also have the capacity to save author-time 
by supplying records in which qualitative and numerical 
data are extracted and referenced.
2. Comparing functionality
Because of the high relevance of screened references 
to the methodology and healthcare condition, having 
a specialized reference-based register does increase 
the sensitivity and specificity of searching for reviews.3 
However, the processes of searching the register, obtaining 
full-text reports of references, screening search results, 
checking each reference based on inclusion criteria, 
assigning references to relevant studies, concatenating data 
from the same study, and coding information/data to link 
references to study36 take time – mostly reviewers’ time. 
A study-based register has, to a greater or lesser extent, 
already undertaken at least some of those tasks moving the 
expense down the line to Information Specialists who are 
more skilled in such types of information management.
Making the move
The Cochrane Dementia and Cognitive Impairment 
Group spent 3 years converting their specialized register 
Figure 1. Example of the relationships within a real world study-based register. This figure shows 17 tables out of 34 tables (tbl) within 
MeerKat, a Microsoft Access-based relational database.23-25 Bibliographic information of each report (in tblReport) is linked to its study (in 
tblStudy). tblStudy is linked to PICO metadata (in tblHealthCareCondition, tblIntervention, tblOutcome) and to relevant systematic review/s 
(in tblReview).
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from reference-based to study-based format.37 We have 
found no other estimates of duration of the switch for 
other groups in health care. This may seem discouraging 
but the initial shift is a matter of days. Fully utilizing 
functionality does, however, take longer. Any initial 
investment is offset by the recognition of the daily 
waste occurring in the systematic reviewing process in 
discarding efforts of reviewers when supplying data to the 
next generation of researchers. The past and considerable 
efforts in concatenation into study and data extraction are 
routinely not re-issued. Repeating such efforts of merging 
(sometimes) hundreds of references into one study is not 
time-efficient. This merging and extraction of data should, 
of course, be entirely transparent to future users (study 
records can potentially hold such tracking information).
As already discussed, a relational database such as 
study-based register has the capacity to provide one-to-
many relationships so that one study with many reports, 
but, in addition, conversely, one report referring to data 
from many studies could be linked and managed easily 
(many-to-one relationships).
1. Developing a register
The development process of specialized registers is 
described in Table 2. For study-based registers, guidelines 
should clarify what fields are required.38,39 As the study 
Table 1. A study record containing the metadata, data extracted from a trial report, and the location of the data within the report
Metadata Data from report(s) Location
Study Name* Jahanian 2014
Reference(s)
1. [Ref. ID 19855] Jahanian AA, Rezaei O, Fadai F, Yaraghchi A. The Effectiveness 
of Rivastigmine in Reducing Tardive Dyskinesia Symptoms in Patients with 
Schizophrenia. Iranian Journal of Psychiatry and Clinical Psychology 2014; 20(1): 
29-34.
2. [Ref. ID 58435] IRCT2012092910964N1. The effectiveness of Rivastigmine on 
reducing the symptoms of Tardive dyskinesia in patients with Schizophrenia. 
Available from [Accessed 29 August 2017]: http://www.irct.ir/searchresult.
php?id=10964&number=1 
Characteristics Location in PDF**
Methods
Allocation: "randomly assigned" no details reported. 19855PG30C1P3L7
Blindness: "double blind" no details reported. 19855PG30C1P3L3
Design: not reported.
Duration: "eight weeks". 19855PG31C1P2L4
Setting: "Razi Psychiatric Center, Tehran, Iran". 19855PG30C1P3L5
Participants
Diagnosis: Patients with schizophrenia and tardive dyskinesia (TD) based on 
DSM-IV-TR diagnosed by psychiatrist.
19855PG30C1P3L12-13
N=40. 19855PG30C1P3L5
Age: range 18-65 years. 19855PG30C1P3L17
Sex: not reported.
Interventions
1. Rivastigmine: dose: 1.5 mg twice daily. N=20. 19855PG30C1P3L7-8
2. Placebo: no details reported. N=20. 19855PG30C1P3L10
Outcomes TD symptoms: no improvement (AIMS). 19855PG31C1P2L5
Notes Sponsorship source: "no financial support". 19855PG33C2P3L1-2
Risk of Bias
Bias Support Statement from Report
Random sequence generation "Randomly". No details. 19855PG30C1P3L7
Allocation concealment Not reported.
Blinding of participants and personnel "Double blind". No details. 19855PG30C1P3L3
Blinding of outcome assessment "Double blind". No details. 19855PG30C1P3L3
Incomplete outcome data Not reported.
Selective reporting None. Registered protocol is available (IRCT2012092910964N1). 19855PG30C1P3L1
Other biases None known.
Outcome
Rivastigmine Placebo
Mean SD Mean SD
AIMS after Intervention 12.5 7.0 10.3 3.1 19855PG32T2
* This example study has two references.
** The first 5 digits refer to the file name, PG to pages, C to column, P to page, L to line, and T to Table.
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record represents the total research activity in the project 
so data may have to be gleaned from different source 
documents. For example, one reference may record 
clinical outcomes of a study. A second reference may 
record economic data missing from the first reference – 
but all are brought together in greater or lesser detail in 
the ‘parent’ study record.40
Those undertaking systematic reviews already extract 
qualitative and quantitative information from all relevant 
references into a study record within their review. These 
data are often structured, use PICO headings and employ 
some sort of controlled vocabulary. These data can form 
the basis of a study record within a register for use by 
others interested in the area and maintenance continues 
as often study records have to be merged. Electronic 
study-register systems often automatically create a study 
record for every reference imported.41 This one-to-one 
relationship is an understandable default but is inaccurate 
and some merging of records will be necessary. This is not 
usually deleting one record in favor of another, but often 
the true merging of records to gain the most accurate 
description of the overall study. If, for example, that third 
reference of a recognizable study is the economics paper, 
and the package has erroneously considered that one 
reference to be a new unique study, it is important that (i) 
the economics outcomes are reported in the ‘parent’ study 
record; (ii) other outcomes are not deleted in favor of only 
economic outcomes; and that (iii) the unneeded study 
record is then deleted but the economics paper’s reference 
record incorporated into the list of citations to that study.
Recognizing references to be of a single study is a skill. 
Usually, references with the same start time, locations, 
interventions and a number of participants are identified 
as references of the same study – although this is not always 
the case.29 Recognition of single studies is assisted by use 
of study acronyms or trial registry number but these, 
unfortunately, remain the exception rather than the rule. 
Some software assists this process by pattern recognition 
within reference records for existing studies. For example, 
machines can recognize if, in a new reference, authors are 
identical to those in an existing study, publication dates 
are very close, interventions and numbers of participants 
are the same. An Information Specialist on top of her/
his topic area quickly gains skills in study recognition. 
Furthermore, those using references and studies within 
reviews have to carefully scrutinize all references. Their 
view of what constitutes a study can be invaluable, 
save much time and be recycled into the Information 
Specialist’s register.
If all steps are followed based on documented guidelines, 
it is easy to organize studies into review clusters. For 
instance, if there are 11 studies comparing ‘Intervention A’ 
versus ‘Intervention B’ for ‘Condition C’, as coded in fields 
of study record, all these studies could be listed under the 
potential review title ‘Intervention A versus intervention 
B for condition C’. This review cluster is appended to with 
incoming relevant studies identified by the Information 
Specialist and, thereafter, end reviewers need to undertake 
little or no additional effort searching or screening.
If the full study data extraction is already undertaken, 
and this is stored within a higher level of study-based 
register, each study record will consist of a dataset in 
tabulated format (for readers) and XML-tagged machine-
readable format (for software in which each piece of data/
information has been linked to its original specific site 
within the source document). Since we could not identify 
any structure to cover a study record in the systematic 
review, Supplementary file 1 demonstrates a proposed 
XML structure to store extracted study data. A standard 
tagged and structured machine-readable framework can 
store data right down to the individual patient data level. 
Structuring for machine-readablity requires knowledge of 
the needs of both reviewers and computer scientists and a 
1. Determining relevance
Screening either references or even an individual full-text report 
of the references may not provide enough information to convince 
the reviewer that the study meets the inclusion criteria.30 Although 
references are assessed, it is the study that is the unit of analysis.
2. Minimizing the over-counting
Treating data from different references of the same study as separate 
studies will result in over-counting and spurious results.29, 31, 32
3. Minimizing the under-counting 
Using data from only a selection of references of the study may fail 
to identify important outcomes in other relevant references of that 
same study. For example protocols of studies may report use of 
many more outcome measures than are finally reported in any one 
reference.20
Box 1. Reasons for assessment and concatenation of all references 
of one study
Table 2. Levels of specialized registers
Beginners’ level or reference-based register 
a. Setting the scope of register
b. Developing, running, documenting, and saving the search strategies
c. De-duplicating and curettage the search results
d. Screening the search results
e. Developing minimum dataset for each reference record
f. Importing the reference records
g. Maintaining the reference records
h. Locating the full texts of all reference records
Intermediate level or study-based register
a. Developing coding scope and guideline for studies
b. Coding or extracting general data from each reference
c. Concatenation, merging, and cleaning the study records
d. Maintaining and updating the study records
Advanced level or automated study-based register 
a. Classifying the studies under each review title ready to be done
b. Developing a machine-readable dataset for each study
c. Extracting all data from each study
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malleable design to be open to future developments. Much 
has already been documented regarding such efforts for 
projects such as Distiller SR, Covidence, and Systematic 
Review Data Repository (SRDR).5,42 
Challenges
1. The concept
The currency of the Information Specialist in health care 
has, for so long, been the individual reference (1 record for 
1 reference) and making the jump to considering studies 
(1 record to potentially many references of 1 study) as the 
primary unit of information can be a conceptual challenge. 
After all, even cursory use of databases such as MEDLINE 
can cause nagging discomfort that information is being 
identified for reviewers that is less ordered and sorted 
than is ideal. For example, searching for CATIE, a large 
trial acronym, in the title field of MEDLINE will reveal 
multiple references (170 references at the time of writing). 
More latterly, solutions to this discomfort been conceived 
and so the issue is more acknowledged.20,29-31 The process 
of systematic reviewing does help make this conceptual 
jump with the use of ‘study tags’ under which all relevant 
references are listed.
In a physical library with books, a librarian undertakes 
collection development, cataloging, classification and 
dissemination of information. A reference-based register 
with just collection development and no coding is the 
equivalent of maintaining a stack of books with no 
classification. Whilst ‘save the time of the reader’ is one 
of Five Laws of Library Science43 ‘save the time of the 
reviewer’ is, we argue, best addressed in a study-based 
register. Also having a reference-based register ‘might 
work’ for some research groups, however, study-based 
register ‘might work even better’ saving the time and 
money for both the Information Specialists and systematic 
reviewers.
2. Responsibility
In reality, the process of identification of studies is a 
shared responsibility between Information Specialist 
and reviewer. Each has different skills to bring to the 
process. The former has competency in the identification 
of records, and knowledge of what each record should 
contain. For example, with reference records indexed 
with study identifiers (e.g., trial registry number), the 
Information Specialist is in a pivotal position to help 
the reviewer avoid needless effort linking references to a 
study. The reviewer, however, having inspected the detail 
of each reference, should be able to supply an authoritative 
study record back to the Information Specialist for their 
use or for the next reviewer. 
Even now the responsibility for concatenation is shared. 
However, study-based registers allow this responsibility to 
be undertaken more easily by the person who maintains 
the register. The nature of systematic reviewing is that 
everything is double checked. By an iterative process, 
the study record evolves to be an increasingly accurate 
report of the primary investigation. To continually pass 
this responsibility down the line to reviewers creates an 
unnecessary waste and opportunity for inaccuracy.
3. Practicalities
For the gains which we outline above, development of 
such a study-based register involves an investment of 
effort – some pain - often from Information Specialists. 
Currently, Information Specialists working in systematic 
reviewing of health care interventions are busy and the 
thought of further work and/or responsibility may be 
unwelcome. However, much current work is inefficient 
and we argue the work creating a study-based register 
is an investment. The ‘pain’ involved makes the role of 
Information Specialist much more sophisticated and 
prepares that person to manage a register suitable for the 
data needs of the 21st century.
Coding of study happens by a shared iterative process 
as outlined above. Many reference records already contain 
study codes which can be imported into the study record. 
For example, the PT field of MEDLINE may contain 
“Randomized Controlled Trial” – a methodological 
term relating to the study, or the SI field contains the 
International Standard Randomized Controlled Trial 
Number (ISRCTN) – again data that relates to the study 
rather than the reference. These data can be imported 
automatically into the study record at no cost of time. As 
reviewers ‘use’ the study, adding to the complexity but also 
the utility of the record, more sophisticated data from this 
investment of effort can be curated and stored ready for 
the next reviewer. 
4. Software
Although there are online clinical trials register such as 
ClinicalTrials.Gov, ISRCTN, and WHO International 
Clinical Trials Registry Platform (including 16 trial 
registers), however, none of these are study-based registers 
and none are aimed to support systematic reviews and 
provide a very limited number of fields for each study 
record. Even before the initiation of these sources, in 1995, 
Cochrane Stroke Group started using study-based register 
and mental health followed.44-49 A year after Stroke Group, 
UK Cochrane Centre supported MeerKat Working Group 
to develop a study-based register system.23,50 In 2003, there 
were 10 Cochrane groups using MeerKat and 5 other 
groups considering its use.23 By 2005, at least 12 Cochrane 
groups (out of 37 responses) were maintaining a study-
based register on MeerKat, ProCite, Reference Manager 
or RefTrak.25,51-53 In 2008, Cochrane started developing a 
new program, Cochrane Register of Studies (CRS), to be 
used by all groups.54-59 A survey in 2014 showed that 8 out 
of 29 respondent groups are using a study-based register 
to some extent.12
There are several reference management programs 
and some study-based register programs. Despite the 
Study-based registers
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decision of Cochrane to move to CRS as the only program 
for managing information on both references and 
studies, groups do tend to use other programs as well as 
CRS.8,9,14,44,60-75 Although others have pioneered software 
for study-based registers44,45 there are few packages that 
are generic, accessible, or customizable. EndNote, ProCite, 
and Reference Manager are popular reference management 
programs that can be modified to include some features 
of study-based registers. These bibliographic packages do 
not lend themselves easily to this adaption and relational 
databases have considerable advantages. Since the purpose 
of programs such as EndNote or Reference Manager is 
not primarily managing studies for systematic reviews, 
using them in a study-based fashion requires time and 
effort – and there is an element of fitting a ‘square-peg-in-
the-round-hole’. Tailor-made relational programs such as 
MeerKat or RefTrak are much better and potentially more 
malleable. CRS continues to evolve. 
No matter what software or application is used, the 
transition to a study-based register necessitates the 
acquisition of a skill-set to use the package to full capacity 
from the study-perspective. This transition is helped by 
practice, training and mentoring.
5. Data ownership
As mentioned before, there are other resources, such as 
online registries of trials, that do provide some useful data 
for studies; however, there are certain barriers in terms of 
copyright and legal issues such as ‘who owns the data’.76 
Such limitations make it hard to use and share the data 
openly and import or share them from other resources in 
study-based registers.
6. Study designs
Since the current development of study-based registers in 
Cochrane, is mainly focused on RCTs/CCTs, and because 
we work within that organization, we have not discussed 
involving other study designs. There is, however, a 
possibility to include all empirical study designs in 
study-based registers of the future. This may cause new 
challenges for the development of the registers involving 
different sets of meta-data. Some Cochrane groups are 
already considering involving more diverse study designs 
in their reviews. However, these other study designs 
are not a priority for consideration in the technological 
development of specialized registers. The development 
of such registers has made it possible to link the studies 
from pre-clinical sciences to clinical sciences. Such link 
could reduce the waste by avoiding a clinical trial research 
where a systematic review of pre-clinical studies about 
ineffectiveness of an intervention exists.77
Gains
Having a study-based register gives review groups the 
advantage of knowing with some accuracy how many 
systematic reviews (or at least comparisons) there are to 
What is current knowledge?
√ A systematic review is required before starting each 
biomedical research. 
√ Doing a systematic review is time-consuming, costly and 
requires training.
√ To do a systematic review, the review team should search 
relevant databases with suitable search strategy, de-duplicate 
the results, screen the results, obtain the full texts, check the 
papers against the eligibility criteria of the review, collect 
the papers relevant to one study under one study name 
(studifying) and then extract and analyze the data.
What is new here?
√ Study-based registers could link the clinical and pre-clinical 
studies related to the same research question to support the 
translational research.
√ Study-based registers are saving the time and cost of 
systematic review for the team skipping the searching, de-
duplicating, screening, finding the full texts, criteria checking 
and studifying steps. The systematic review could start with 
data extraction or meta-analysis.
√ There are three different levels of specialized registers which 
are now the milestone of automation of systematic reviews.
Methodology Highlights
cover in a topic area – and to more accurately estimate the 
future work-load.78 Such knowledge allows accurate and 
efficient prioritization of effort. 
Current resources, if used effectively, are sufficient to 
increase productivity. Using the study as the currency of 
the Information Specialist, modifying that role within 
a review group to create and maintain the study-based 
register, and finally using such a register will greatly 
increase the pace and efficiently of information exchange. 
Information Specialists could then undertake regular – 
perhaps semi-automated – searches, screen, and code and 
include relevant records within the study-based register. 
New references of existing studies would be added to 
the existing record and, if this study is used within an 
existing review, the reviewers would be notified. New 
studies relevant to existing review topics would also cause 
reviewers to be alerted. Rather than passively waiting 
for reviewers to request update searches Information 
Specialists would be proactive in helping the update. 
From the ordered study-based register studies can be 
linked to topics and be instantly ready for new reviewers. 
Should data from a study have been extracted for use in an 
existing review, these detailed data could be supplied from 
a sophisticated study-based register in an appropriate 
format to anyone undertaking a new review necessitating 
the use of the same study.
Conclusions
The ultimate goal of having a study-based register is 
to facilitate efficient production of systematic reviews 
Shokraneh and Adams
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providing rapid but accurate evidence for decision-
makers. The future will involve increasing automation. 
Document optimization now allows much more reliable 
auto-data extraction.79 Programs already exist for semi-
automated data extraction from randomized trials5 and 
text mining techniques are increasingly sophisticated. The 
automatic synthesis of data is not far away, perhaps driven 
by users’ needs rather than those of policymakers. Limited 
automatic write-up of synthesized evidence already 
exists.79-81 These next years will see a swift synthesis of 
best and personalized evidence of the effects of health 
care in the hands of anyone. At the heart of this exciting 
prospect should be the role of the Information Specialist 
– but a role fit for the 21st century and not one that is 
dated and wasteful. Moving from reference-based register 
toward study-based register is, we think, inevitable. The 
infrastructures are ready for such movement.
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